Armata Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ARMP, updated each market day.
ARMP AI Sentiment
AI predicts Armata Pharmaceuticals, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Armata Pharmaceuticals, Inc. Common Stock
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Sector
Exchange
Market Cap
$422,375,895
Cap Tier
Employees
61
Headquarters
LOS ANGELES, CA
Listed Since
May 27, 1994
Website
ARMP Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ARMP Volatility
Armata Pharmaceuticals, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
